semaglutide news today october 2025 Troubling Findings in Study of GLP-1 Compounders Semaglutide: Shedding pounds, weighing risks

Advert A trial conducted by the pharmaceutical company found that participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7 percent of their body weight at 68 weeks, per a press release

All tests were two-sided and P 0.05 was considered statistically significant

Many of these challengesparticularly those related to polycystic ovary syndrome (PCOS), irregular ovulation, or unexplained infertilityare influenced by underlying metabolic health

Reduce Inflammation : GHK-Cu peptides help calm inflammation, making this treatment ideal for individuals with sensitive or acne-prone skin

Ozempic Alternatives In addition to Wegovy, Mounjaro and Ozempic, Saxenda (liraglutide) and Trulicity (dulaglutide) are other weight loss options that work similarly

Consequently, weight reduction and caloric restriction remain important contributors to metabolic improvements